SUNOSI 75 mg/1
solriamfetol · TABLET, FILM COATED · Axsome Therapeutics, Inc.
No Recall History
Plain English
SUNOSI is a tablet, film coated containing solriamfetol at 75 mg/1, taken oral. Manufactured by Axsome Therapeutics, Inc..
Key Facts
- Brand Name
- SUNOSI
- Generic Name
- solriamfetol
- NDC Code (Product)
81968-350- Manufacturer
- Axsome Therapeutics, Inc.
- Strength
- 75 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- DEA Schedule
- Schedule IV (Controlled)
- Application #
- NDA211230
- Drug Class
- Dopamine and Norepinephrine Reuptake Inhibitor [EPC]
- Marketing Start
- 06/18/2019
Recall History
No Recall HistoryFrequently Asked Questions
What is SUNOSI used for?
SUNOSI contains solriamfetol. It is a tablet, film coated taken oral. Consult your doctor for specific uses.
Is SUNOSI a controlled substance?
Yes, SUNOSI is classified as CIV under the DEA Controlled Substances Act.
What is the generic name for SUNOSI?
The generic name for SUNOSI is solriamfetol. There are no other listed brand versions of solriamfetol.
What is the NDC code for SUNOSI 75 mg/1?
The NDC (National Drug Code) for SUNOSI 75 mg/1 is 81968-350, listed by Axsome Therapeutics, Inc..
Other SUNOSI Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)